aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Sale and Maturity of Investments (2014 - 2026)

Updated

Analysis

aTYR PHARMA (ATYR) Sale and Maturity of Investments (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 aTYR PHARMA 16.67 Mn -276.34 Mn - 23.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.37 Mn
Mar 31, 2026 17.50 Mn
Dec 31, 2025 29.31 Mn
Sep 30, 2025 19.00 Mn
Jun 30, 2025 21.47 Mn
Mar 31, 2025 18.69 Mn
Dec 31, 2024 20.00 Mn
Sep 30, 2024 20.87 Mn
Jun 30, 2024 25.52 Mn
Mar 31, 2024 20.00 Mn
Dec 31, 2023 27.50 Mn
Sep 30, 2023 33.55 Mn
Jun 30, 2023 20.70 Mn
Mar 31, 2023 9.30 Mn
Dec 31, 2022 28.11 Mn
Sep 30, 2022 27.01 Mn
Jun 30, 2022 21.20 Mn
Mar 31, 2022 14.50 Mn
Dec 31, 2021 8.32 Mn
Sep 30, 2021 14.00 Mn
API Access

aTYR PHARMA Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ATYR&period=max&api_key=YOUR_API_KEY